PT1009743E - Certos antagonistas da endotelina a base de dioxido de benzotiazina e processos para a sua preparacao - Google Patents
Certos antagonistas da endotelina a base de dioxido de benzotiazina e processos para a sua preparacaoInfo
- Publication number
- PT1009743E PT1009743E PT98942061T PT98942061T PT1009743E PT 1009743 E PT1009743 E PT 1009743E PT 98942061 T PT98942061 T PT 98942061T PT 98942061 T PT98942061 T PT 98942061T PT 1009743 E PT1009743 E PT 1009743E
- Authority
- PT
- Portugal
- Prior art keywords
- benzotiazine
- dioxide
- processes
- preparation
- certain
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5811197P | 1997-09-05 | 1997-09-05 | |
US9232698P | 1998-07-09 | 1998-07-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1009743E true PT1009743E (pt) | 2004-09-30 |
Family
ID=26737251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98942061T PT1009743E (pt) | 1997-09-05 | 1998-08-13 | Certos antagonistas da endotelina a base de dioxido de benzotiazina e processos para a sua preparacao |
Country Status (24)
Country | Link |
---|---|
US (5) | US6265399B1 (pt) |
EP (1) | EP1009743B1 (pt) |
JP (1) | JP2001515893A (pt) |
KR (1) | KR20010023686A (pt) |
AR (1) | AR017056A1 (pt) |
AT (1) | ATE270281T1 (pt) |
AU (1) | AU759169B2 (pt) |
BR (1) | BR9812431A (pt) |
CA (1) | CA2296358A1 (pt) |
CO (1) | CO4970725A1 (pt) |
DE (1) | DE69824863T2 (pt) |
ES (1) | ES2221191T3 (pt) |
HU (1) | HUP0003689A3 (pt) |
IL (1) | IL134057A0 (pt) |
IS (1) | IS5356A (pt) |
MY (1) | MY116277A (pt) |
NO (1) | NO20001078D0 (pt) |
NZ (1) | NZ502670A (pt) |
PE (1) | PE116699A1 (pt) |
PL (1) | PL338983A1 (pt) |
PT (1) | PT1009743E (pt) |
TW (1) | TW508355B (pt) |
UY (1) | UY25168A1 (pt) |
WO (1) | WO1999012916A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU759169B2 (en) | 1997-09-05 | 2003-04-10 | Warner-Lambert Company | Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
WO2001083431A1 (fr) * | 2000-04-28 | 2001-11-08 | Shionogi & Co., Ltd. | Inhibiteurs de mmp-12 |
MXPA02010764A (es) * | 2000-05-31 | 2003-03-10 | Warner Lambert Co | Combinaciones de un antagonista del receptor endotelina y un compuesto antiepileptico que tiene propiedades para aliviar el dolor o analgesico. |
US20020115661A1 (en) * | 2000-12-07 | 2002-08-22 | Keller Laurence Harvey | Method for treating chronic obstructive pulmonary disease |
WO2005051298A2 (en) | 2003-11-19 | 2005-06-09 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
FR2874011B1 (fr) | 2004-08-03 | 2007-06-15 | Sanofi Synthelabo | Derives de sulfonamides, leur preparation et leur application en therapeutique |
DE102008026894A1 (de) * | 2008-06-05 | 2009-12-10 | Evonik Degussa Gmbh | Ink Jet Tinte |
CA2969756A1 (en) * | 2014-12-05 | 2016-06-09 | Aquinnah Pharmaceuticals, Inc. | Sulfonamide derivatives, compositions and methods of use in the treatment of neurodegenerative diseases |
CN108727176B (zh) * | 2018-07-26 | 2021-05-18 | 荆楚理工学院 | 一种制备5-卤-2,3-二羟基苯甲醛的方法 |
CN113214299A (zh) * | 2021-03-01 | 2021-08-06 | 重庆西南制药二厂有限责任公司 | γ-联苯双酯中间体及合成方法及γ-联苯双酯合成方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3960856A (en) * | 1975-06-20 | 1976-06-01 | Warner-Lambert Company | Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide |
IN159273B (pt) * | 1981-10-05 | 1987-04-25 | Pfizer | |
JPH0495057A (ja) * | 1990-08-08 | 1992-03-27 | Taisho Pharmaceut Co Ltd | N―置換スルホンアニリド化合物 |
US5389620A (en) | 1993-08-18 | 1995-02-14 | Banyu Pharmaceutical Co., Ltd. | Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
EP0714897B1 (en) * | 1993-08-18 | 2001-02-14 | Banyu Pharmaceutical Co., Ltd. | Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity |
JPH0912562A (ja) | 1995-06-22 | 1997-01-14 | Suntory Ltd | 置換ベンゾチアジン誘導体 |
CA2156849A1 (en) | 1993-12-24 | 1995-07-06 | Akira Mizuno | Benzothiazine derivative |
US5482960A (en) | 1994-11-14 | 1996-01-09 | Warner-Lambert Company | Nonpeptide endothelin antagonists |
US5599811A (en) * | 1995-02-21 | 1997-02-04 | Warner-Lambert Company | Benzothiazine dioxides as endothelin antagonists |
CA2190708A1 (en) | 1995-12-08 | 1997-06-09 | Johannes Aebi | Aminoalkyl substituted benzo-heterocyclic compounds |
AU759169B2 (en) | 1997-09-05 | 2003-04-10 | Warner-Lambert Company | Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
-
1998
- 1998-08-13 AU AU90196/98A patent/AU759169B2/en not_active Ceased
- 1998-08-13 HU HU0003689A patent/HUP0003689A3/hu unknown
- 1998-08-13 JP JP2000510724A patent/JP2001515893A/ja not_active Abandoned
- 1998-08-13 WO PCT/US1998/016856 patent/WO1999012916A1/en active IP Right Grant
- 1998-08-13 IL IL13405798A patent/IL134057A0/xx unknown
- 1998-08-13 US US09/445,504 patent/US6265399B1/en not_active Expired - Fee Related
- 1998-08-13 EP EP98942061A patent/EP1009743B1/en not_active Expired - Lifetime
- 1998-08-13 PT PT98942061T patent/PT1009743E/pt unknown
- 1998-08-13 CA CA002296358A patent/CA2296358A1/en not_active Abandoned
- 1998-08-13 PL PL98338983A patent/PL338983A1/xx unknown
- 1998-08-13 NZ NZ502670A patent/NZ502670A/xx unknown
- 1998-08-13 ES ES98942061T patent/ES2221191T3/es not_active Expired - Lifetime
- 1998-08-13 KR KR1020007002339A patent/KR20010023686A/ko not_active Application Discontinuation
- 1998-08-13 DE DE69824863T patent/DE69824863T2/de not_active Expired - Fee Related
- 1998-08-13 AT AT98942061T patent/ATE270281T1/de not_active IP Right Cessation
- 1998-08-13 BR BR9812431-5A patent/BR9812431A/pt not_active Application Discontinuation
- 1998-09-03 MY MYPI98004024A patent/MY116277A/en unknown
- 1998-09-04 CO CO98050781A patent/CO4970725A1/es unknown
- 1998-09-04 UY UY25168A patent/UY25168A1/es not_active IP Right Cessation
- 1998-09-04 PE PE1998000822A patent/PE116699A1/es not_active Application Discontinuation
- 1998-09-04 AR ARP980104414A patent/AR017056A1/es unknown
- 1998-10-28 TW TW087114760A patent/TW508355B/zh not_active IP Right Cessation
-
2000
- 2000-01-21 IS IS5356A patent/IS5356A/is unknown
- 2000-03-02 NO NO20001078A patent/NO20001078D0/no unknown
- 2000-08-07 US US09/633,720 patent/US6252070B1/en not_active Expired - Fee Related
-
2001
- 2001-03-27 US US09/818,394 patent/US6440962B2/en not_active Expired - Fee Related
- 2001-12-05 US US10/006,589 patent/US6545150B2/en not_active Expired - Fee Related
-
2002
- 2002-06-03 US US10/161,569 patent/US20030073684A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2296358A1 (en) | 1999-03-18 |
US6440962B2 (en) | 2002-08-27 |
US20020094980A1 (en) | 2002-07-18 |
DE69824863T2 (de) | 2005-06-30 |
CO4970725A1 (es) | 2000-11-07 |
HUP0003689A3 (en) | 2003-05-28 |
MY116277A (en) | 2003-12-31 |
EP1009743B1 (en) | 2004-06-30 |
US6252070B1 (en) | 2001-06-26 |
US20030073684A1 (en) | 2003-04-17 |
AR017056A1 (es) | 2001-08-22 |
ES2221191T3 (es) | 2004-12-16 |
UY25168A1 (es) | 1999-05-14 |
NZ502670A (en) | 2003-01-31 |
IS5356A (is) | 2000-01-21 |
AU759169B2 (en) | 2003-04-10 |
PL338983A1 (en) | 2000-12-04 |
JP2001515893A (ja) | 2001-09-25 |
US20010036944A1 (en) | 2001-11-01 |
DE69824863D1 (de) | 2004-08-05 |
WO1999012916A1 (en) | 1999-03-18 |
US6545150B2 (en) | 2003-04-08 |
BR9812431A (pt) | 2000-09-19 |
IL134057A0 (en) | 2001-04-30 |
EP1009743A1 (en) | 2000-06-21 |
HUP0003689A2 (hu) | 2001-09-28 |
KR20010023686A (ko) | 2001-03-26 |
US6265399B1 (en) | 2001-07-24 |
NO20001078L (no) | 2000-03-02 |
PE116699A1 (es) | 1999-12-19 |
ATE270281T1 (de) | 2004-07-15 |
AU9019698A (en) | 1999-03-29 |
TW508355B (en) | 2002-11-01 |
NO20001078D0 (no) | 2000-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT881906E (pt) | Composicao farmaceutica para a imunomodelacao baseada em peptideos e adjuvantes | |
MX9904749A (es) | Composiciones a base de esfingomielanasa y su utilizacion. | |
FR2727002B1 (fr) | Prothese humerale a sphere | |
LV11460A (lv) | Estrogenu agonisti un antagonisti | |
DE59707778D1 (de) | Gelenkendoprothese | |
DK0915701T3 (da) | Hurtigoplöselige galanthaminhydrobromidtabletter | |
IT1294729B1 (it) | Procedimento e dispositivo per la fabbricazione a macchina di un libro e simili | |
DE69824980D1 (de) | Beleuchtete Taste | |
GB2320717B (en) | Novel amide- or imide-introduced copolymer preparation thereof and a photoresist comprising the same | |
PT994956E (pt) | Regiao reguladora preferida por tecido masculino e metodo para a sua utilizacao | |
PT1015444E (pt) | Derivados de pirimidina e processos para a sua preparacao | |
PT1009743E (pt) | Certos antagonistas da endotelina a base de dioxido de benzotiazina e processos para a sua preparacao | |
EE200000181A (et) | Identifitseerimisseade ja -meetod | |
FR2752377B1 (fr) | Biberon a fond amovible | |
DE59707485D1 (de) | Kontaktstift | |
CZ2000522A3 (cs) | Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití | |
AU1949399A (en) | Kelvin contact-type testing device | |
PT1037652E (pt) | Composicoes farmaceuticas a base de dalfopristina e de quinupristina e sua preparacao | |
NL1003271A1 (nl) | Stalvloer alsmede vloerelement voor toepassing in een dergelijke vloer. | |
DK0929521T3 (da) | NMDA-antagonister (N-methyl-D-aspartat-antagnonister) | |
FR2755857B1 (fr) | Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation | |
BR9610049A (pt) | Composições endoparasiticidas à base de didepsipeptídeos novos didepsipeptídeos e processos para a sua preparação | |
DE69832919D1 (de) | Bilderzeugungsgerät und eine in diesem eingesetzte abnehmbare Einheit | |
BR9710568A (pt) | Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2 | |
AU3116697A (en) | Human interleukin-1j and antagonists thereof |